Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Filings indexed 780 across all filing types
Latest filing 2009-09-03 Capital/Financing Update
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to Form S-1, which is a registration statement filed with the SEC under the Securities Act of 1933. It relates to the registration of shares for public offering by a selling shareholder. The text includes details about the offering, risk factors, company background, and use of proceeds. This type of filing is a capital markets document related to fundraising and securities registration, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, confirming it is not a mere announcement or certification. Confidence is high due to clear identification of the form and content.
2009-09-03 English
Major Shareholding Notification 2009
Major Shareholding Notification
2009-09-02 English
FORM 4
Director's Dealing
2009-09-02 English
EQUITY 11 6TH TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 1, 2009. It reports an unregistered sale of equity securities (Convertible Preferred Shares) and provides details about the transaction and related agreements. There are no financial statements or exhibits included, and the document is relatively short (4201 characters). The content focuses on a capital transaction update rather than a full financial report or earnings release. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Therefore, this document is best classified as a Capital/Financing Update (CAP).
2009-09-01 English
REYNOLDS COLLABORATION AGREEMENT 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing with the SEC, which is used for current reports to announce major events that shareholders should know about. The text describes the entry into a material definitive agreement (a collaboration agreement) and includes details about the agreement terms and potential payments. It does not contain financial statements or detailed financial performance data. The document is not an annual or quarterly report, earnings release, or any other detailed financial report. It is a regulatory announcement of a significant event (collaboration agreement) and thus fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. The document length is short (3206 characters), and it is not an announcement of a report publication but the report itself of a current event.
2009-08-24 English
Major Shareholding Notification 2009
Major Shareholding Notification
2009-08-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.